6101 - 6150 of 8715 Results
Title
Year
-
RESTRICTEDTitle: A suggested minimum standard deep brain stimulation evaluation for essential tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 362Issue #:Start Page: 165End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.01.041Citation Count: 8
-
OPENTitle: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 45Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2111643118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8694049Citation Count: 65
-
OPENTitle: Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00346-0Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00346-0Citation Count: 26
-
RESTRICTEDTitle: Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf201Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf201/63485731/awaf201.pdfCitation Count: 1
-
OPENTitle: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based studyJournal Name: Environmental ResearchPublisher: Elsevier BVVol: 229Issue #:Start Page: 115944End Page: 115944Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envres.2023.115944Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0013935123007363-ga1_lrg.jpgCitation Count: 11
-
OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
-
RESTRICTEDTitle: Neuropsychological impairment in prodromal Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 371Issue #:Start Page: 117End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007Citation Count: 14
-
OPENTitle: Neurophysiological Correlates of Gait in the Human Basal Ganglia and the PPN Region in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.00194Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.00194/pdfCitation Count: 27
- TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects2018OPENTitle: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite EffectsJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 64Issue #: 3Start Page: 341End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4Best OA location URL: https://zenodo.org/record/3911331Citation Count: 12
-
RESTRICTEDTitle: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide StandardJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 6Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920Citation Count: 15
-
OPENTitle: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00451-xBest OA location URL: https://www.nature.com/articles/s41531-023-00451-x.pdfCitation Count: 10
-
OPENTitle: Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 12Start Page: 3828End Page: 3833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.16039Citation Count: 29
-
OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 123
-
OPENTitle: Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 IsoformsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 2018End Page: 2027Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00029Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00029Citation Count: 1
-
RESTRICTEDTitle: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cellsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 202Issue #:Start Page: 108End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005Citation Count: 19
-
OPENTitle: A cholinergic contribution to postural control and freezing of gait in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3110End Page: 3111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad223Best OA location URL: https://academic.oup.com/brain/article-pdf/146/8/3110/51018614/awad223.pdfCitation Count: 0
-
OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 50
-
RESTRICTEDTitle: Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA MutationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 106End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28818Citation Count: 25
-
OPENTitle: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variantJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 6Start Page: 1996End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae073Best OA location URL: https://doi.org/10.1093/brain/awae073Citation Count: 21
-
RESTRICTEDTitle: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonistJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 398Issue #: 1Start Page: 991End Page: 1002Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0Best OA location URL: https://hal.science/hal-04932477Citation Count: 1
- Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils2025OPENTitle: Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrilsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-025-08786-2Best OA location URL: https://doi.org/10.1038/s42003-025-08786-2Citation Count: 0
-
RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 43
-
OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
-
OPENTitle: Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein FibrilsJournal Name: NeurosciencePublisher: Elsevier BVVol: 437Issue #:Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.04.032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7510511Citation Count: 19
-
OPENTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 13
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 46
-
OPENTitle: Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screeningJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 47Start Page: 12746End Page: 12754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d0sc02159hBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2020/sc/d0sc02159hCitation Count: 47
-
OPENTitle: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoidsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202107135Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202107135/1428539/jcb_202107135.pdfCitation Count: 21
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4855523Citation Count: 282
- No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease2019OPENTitle: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 87Issue #:Start Page: 140.e19End Page: 140.e22Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0197458019303951Citation Count: 13
-
OPENTitle: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 704End Page: 717Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11481-023-10094-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-023-10094-7.pdfCitation Count: 5
-
RESTRICTEDTitle: At last, a randomised controlled trial of apomorphine infusionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 732End Page: 733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9Citation Count: 3
-
OPENTitle: Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individualsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 45Issue #: 10Start Page: 1241End Page: 1251Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13408Citation Count: 9
-
OPENTitle: Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01010-2Best OA location URL: https://www.nature.com/articles/s41531-025-01010-2.pdfCitation Count: 0
-
OPENTitle: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese populationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 659End Page: 661Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.03.004Best OA location URL: http://doi.org/10.1016/j.parkreldis.2014.03.004Citation Count: 15
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 1
-
OPENTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://doi.org/10.1021/acschemneuro.3c00437Citation Count: 16
-
OPENTitle: Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-40348-0Best OA location URL: https://www.nature.com/articles/s41467-023-40348-0.pdfCitation Count: 37
-
OPENTitle: Sex differences in the diagnosis latency of Parkinson's disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107344End Page: 107344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107344Citation Count: 0
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://repositorio.uchile.cl/handle/2250/165323Citation Count: 17
-
RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 21
-
OPENTitle: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2086Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2086Citation Count: 6
-
RESTRICTEDTitle: Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 43End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.009Citation Count: 53
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 45
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation2022RESTRICTEDTitle: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and DifferentiationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 23Start Page: 3281End Page: 3290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12316044Citation Count: 11
-
OPENTitle: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegenerationJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-023-02338-1Best OA location URL: https://www.nature.com/articles/s41597-023-02338-1.pdfCitation Count: 1
-
OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1